Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Papadopoulos

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
Molecular Immunology|March 21, 2001
Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognitionD B De Oliveira, E Harfouch-Hammoud, H Otto, et al.
Diabetes|July 13, 2012
Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis studyAhmed J Delli, Fariba Vaziri-Sani, Bengt Lindblad, et al.
Journal of Personalized Medicine|August 26, 2022
Enhancing Anticoagulation Monitoring and Therapy in Patients Undergoing Microvascular Reconstruction in Maxillofacial Surgery: A Prospective Observational TrialTom A Schröder, Henry Leonhardt, Dominik Haim, et al.
Diabetologia|October 1, 2024
Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimersLue Ping Zhao, George K Papadopoulos, Jay S Skyler, et al.
Heart (British Cardiac Society)|March 9, 2007
The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarctionS G Foussas, M N Zairis, S S Makrygiannis, et al.
Diabetes Care|March 18, 2024
HLA Class II (DR, DQ, DP) Genes Were Separately Associated With the Progression From Seroconversion to Onset of Type 1 Diabetes Among Participants in Two Diabetes Prevention Trials (DPT-1 and TN07)Lue Ping Zhao, George K Papadopoulos, Jay S Skyler, et al.
Science (New York, N.Y.)|April 14, 2018
RNA buffers the phase separation behavior of prion-like RNA binding proteinsShovamayee Maharana, Jie Wang, Dimitrios K Papadopoulos, et al.
Diabetes|September 2, 2020
Next-Generation HLA Sequence Analysis Uncovers Seven HLA-DQ Amino Acid Residues and Six Motifs Resistant to Childhood Type 1 DiabetesLue Ping Zhao, George K Papadopoulos, William W Kwok, et al.
British Journal of Cancer|September 1, 2011
Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancerA C Mita, K Papadopoulos, M J A de Jonge, et al.
Diabetologia|September 27, 2025
Correction: Profiling associations of interactive ligand-receptors (HLA class I and KIR gene products) with the progression to type 1 diabetes among seroconverted participantsLue Ping Zhao, George K Papadopoulos, Benjamin J McFarland, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Molecular Immunology|March 21, 2001
Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognitionD B De Oliveira, E Harfouch-Hammoud, H Otto, et al.
Diabetes|July 13, 2012
Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis studyAhmed J Delli, Fariba Vaziri-Sani, Bengt Lindblad, et al.
Journal of Personalized Medicine|August 26, 2022
Enhancing Anticoagulation Monitoring and Therapy in Patients Undergoing Microvascular Reconstruction in Maxillofacial Surgery: A Prospective Observational TrialTom A Schröder, Henry Leonhardt, Dominik Haim, et al.
Diabetologia|October 1, 2024
Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimersLue Ping Zhao, George K Papadopoulos, Jay S Skyler, et al.
Heart (British Cardiac Society)|March 9, 2007
The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarctionS G Foussas, M N Zairis, S S Makrygiannis, et al.
Diabetes Care|March 18, 2024
HLA Class II (DR, DQ, DP) Genes Were Separately Associated With the Progression From Seroconversion to Onset of Type 1 Diabetes Among Participants in Two Diabetes Prevention Trials (DPT-1 and TN07)Lue Ping Zhao, George K Papadopoulos, Jay S Skyler, et al.
Science (New York, N.Y.)|April 14, 2018
RNA buffers the phase separation behavior of prion-like RNA binding proteinsShovamayee Maharana, Jie Wang, Dimitrios K Papadopoulos, et al.
Diabetes|September 2, 2020
Next-Generation HLA Sequence Analysis Uncovers Seven HLA-DQ Amino Acid Residues and Six Motifs Resistant to Childhood Type 1 DiabetesLue Ping Zhao, George K Papadopoulos, William W Kwok, et al.
British Journal of Cancer|September 1, 2011
Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancerA C Mita, K Papadopoulos, M J A de Jonge, et al.
Diabetologia|September 27, 2025
Correction: Profiling associations of interactive ligand-receptors (HLA class I and KIR gene products) with the progression to type 1 diabetes among seroconverted participantsLue Ping Zhao, George K Papadopoulos, Benjamin J McFarland, et al.
Pageof 18